Company Filing History:
3 out of 486 
2 out of 1,217 
1 out of 851 Years Active: 1979-2009
Title: John L Gerin: Innovator in Hepatitis Delta Virus Treatment
Introduction
John L Gerin is a notable inventor based in Bethesda, MD (US), recognized for his contributions to medical science, particularly in the treatment of hepatitis delta virus infection. With a total of 6 patents, Gerin has made significant strides in developing methods that aim to improve patient outcomes.
Latest Patents
Gerin's latest patents focus on innovative methods for treating hepatitis delta virus infection. One of his key inventions involves a method that includes administering an effective amount of a nucleoside or a nucleoside analog. This treatment suppresses the expression of the hepatitis B surface or preS1 antigen in the host by 100-fold or more relative to pretreatment values in vivo. In a preferred embodiment, the nucleoside used is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.
Career Highlights
Throughout his career, John L Gerin has worked with prestigious institutions, including Georgetown University and the United States of America as represented by the Department of Health. His work has been pivotal in advancing the understanding and treatment of viral infections.
Collaborations
Gerin has collaborated with notable colleagues such as Brent E Korba and John L Casey, contributing to a rich exchange of ideas and research in the field of virology.
Conclusion
John L Gerin's innovative work in the treatment of hepatitis delta virus infection showcases his dedication to improving healthcare through scientific research and invention. His contributions continue to influence the medical community and offer hope for effective treatments.